Overactive Bladder
Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection - Abstract
October 1, 2012
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis - Abstract
September 28, 2012
Detrusor myectomy: Long-term functional outcomes - Abstract
September 27, 2012
Intradetrusor versus suburothelial onabotulinumtoxinA injections for neurogenic detrusor overactivity: A pilot study - Abstract
September 26, 2012
Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools - Abstract
September 25, 2012
Oxybutynin: Past, present, and future - Abstract
September 24, 2012
Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms - Abstract
September 20, 2012
Intradetrusor injection of botulinum toxin for the management of refractory overactive bladder syndrome: An update - Abstract
September 19, 2012
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity - Abstract
September 17, 2012
Botulinum toxin versus sacral neuromodulation for idiopathic detrusor overactivity - Abstract
September 13, 2012
Neurogenic lower urinary tract dysfunction--do we need same session repeat urodynamic investigations? - Abstract
September 12, 2012
Analysis of the risk factors for overactive bladder on the basis of a survey in the community - Abstract
September 11, 2012
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder - Abstract
September 10, 2012
Association of symptoms with urodynamic findings in men with overactive bladder syndrome - Abstract
September 7, 2012